The architecture of diagnostic research

From bench to bedside-research guidelines using liver stiffness as an example

Agostino Colli, Mirella Fraquelli, Giovanni Casazza, Dario Conte, Dimitrinka Nikolova, Piergiorgio Duca, Kristian Thorlund, Christian Gluud

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

The diagnostic research process can be divided into five phases, designed to establish the clinical utility of a new diagnostic test-the index test. The aim of the present review is to illustrate the study designs that are appropriate for each diagnostic phase, using clinical examples regarding liver fibrosis diagnosed with transient elastography, when possible. Phase 0 is the preclinical pilot phase during which the validity, reliability, and reproducibility of the index test are assessed in healthy and diseased people. Phase I is designed to describe the distribution of the index test results in healthy people and its normal values. Phase IIA comprises studies designed to estimate the accuracy (sensitivity and specificity) of the index test in discriminating between diseased and nondiseased people in a clinically relevant population. Phase IIB studies allow the comparison of the accuracy of different index tests; Phase IIC studies aim to evaluate the possible harms of incorporating the index test in a diagnostic-therapeutic strategy. In phase III, diagnostic test-therapeutic randomized clinical trials aim to assess the benefits and harms of the new diagnostic-therapeutic strategy versus the present strategy. Phase IV comprises large surveillance cohort studies that aim to assess the effectiveness of the new diagnostic-therapeutic strategy in clinical practice. Conclusion: As common in clinical research, giving excessive weight to the results of single studies and trials is likely to divert from the totality of evidence obtained through the systematic reviews of these studies, conducted with rigorous methodology and statistical methods. (Hepatology 2014;60:408-418)

Original languageEnglish
Pages (from-to)408-418
Number of pages11
JournalHepatology
Volume60
Issue number1
DOIs
Publication statusPublished - 2014

Fingerprint

Guidelines
Liver
Research
Routine Diagnostic Tests
Elasticity Imaging Techniques
Gastroenterology
Therapeutics
Reproducibility of Results
Liver Cirrhosis
Reference Values
Cohort Studies
Randomized Controlled Trials
Weights and Measures
Sensitivity and Specificity
Population

ASJC Scopus subject areas

  • Hepatology

Cite this

The architecture of diagnostic research : From bench to bedside-research guidelines using liver stiffness as an example. / Colli, Agostino; Fraquelli, Mirella; Casazza, Giovanni; Conte, Dario; Nikolova, Dimitrinka; Duca, Piergiorgio; Thorlund, Kristian; Gluud, Christian.

In: Hepatology, Vol. 60, No. 1, 2014, p. 408-418.

Research output: Contribution to journalArticle

Colli, A, Fraquelli, M, Casazza, G, Conte, D, Nikolova, D, Duca, P, Thorlund, K & Gluud, C 2014, 'The architecture of diagnostic research: From bench to bedside-research guidelines using liver stiffness as an example', Hepatology, vol. 60, no. 1, pp. 408-418. https://doi.org/10.1002/hep.26948
Colli, Agostino ; Fraquelli, Mirella ; Casazza, Giovanni ; Conte, Dario ; Nikolova, Dimitrinka ; Duca, Piergiorgio ; Thorlund, Kristian ; Gluud, Christian. / The architecture of diagnostic research : From bench to bedside-research guidelines using liver stiffness as an example. In: Hepatology. 2014 ; Vol. 60, No. 1. pp. 408-418.
@article{eb42a51652d047b095c1cee2949b4494,
title = "The architecture of diagnostic research: From bench to bedside-research guidelines using liver stiffness as an example",
abstract = "The diagnostic research process can be divided into five phases, designed to establish the clinical utility of a new diagnostic test-the index test. The aim of the present review is to illustrate the study designs that are appropriate for each diagnostic phase, using clinical examples regarding liver fibrosis diagnosed with transient elastography, when possible. Phase 0 is the preclinical pilot phase during which the validity, reliability, and reproducibility of the index test are assessed in healthy and diseased people. Phase I is designed to describe the distribution of the index test results in healthy people and its normal values. Phase IIA comprises studies designed to estimate the accuracy (sensitivity and specificity) of the index test in discriminating between diseased and nondiseased people in a clinically relevant population. Phase IIB studies allow the comparison of the accuracy of different index tests; Phase IIC studies aim to evaluate the possible harms of incorporating the index test in a diagnostic-therapeutic strategy. In phase III, diagnostic test-therapeutic randomized clinical trials aim to assess the benefits and harms of the new diagnostic-therapeutic strategy versus the present strategy. Phase IV comprises large surveillance cohort studies that aim to assess the effectiveness of the new diagnostic-therapeutic strategy in clinical practice. Conclusion: As common in clinical research, giving excessive weight to the results of single studies and trials is likely to divert from the totality of evidence obtained through the systematic reviews of these studies, conducted with rigorous methodology and statistical methods. (Hepatology 2014;60:408-418)",
author = "Agostino Colli and Mirella Fraquelli and Giovanni Casazza and Dario Conte and Dimitrinka Nikolova and Piergiorgio Duca and Kristian Thorlund and Christian Gluud",
year = "2014",
doi = "10.1002/hep.26948",
language = "English",
volume = "60",
pages = "408--418",
journal = "Hepatology",
issn = "0270-9139",
publisher = "John Wiley and Sons Inc.",
number = "1",

}

TY - JOUR

T1 - The architecture of diagnostic research

T2 - From bench to bedside-research guidelines using liver stiffness as an example

AU - Colli, Agostino

AU - Fraquelli, Mirella

AU - Casazza, Giovanni

AU - Conte, Dario

AU - Nikolova, Dimitrinka

AU - Duca, Piergiorgio

AU - Thorlund, Kristian

AU - Gluud, Christian

PY - 2014

Y1 - 2014

N2 - The diagnostic research process can be divided into five phases, designed to establish the clinical utility of a new diagnostic test-the index test. The aim of the present review is to illustrate the study designs that are appropriate for each diagnostic phase, using clinical examples regarding liver fibrosis diagnosed with transient elastography, when possible. Phase 0 is the preclinical pilot phase during which the validity, reliability, and reproducibility of the index test are assessed in healthy and diseased people. Phase I is designed to describe the distribution of the index test results in healthy people and its normal values. Phase IIA comprises studies designed to estimate the accuracy (sensitivity and specificity) of the index test in discriminating between diseased and nondiseased people in a clinically relevant population. Phase IIB studies allow the comparison of the accuracy of different index tests; Phase IIC studies aim to evaluate the possible harms of incorporating the index test in a diagnostic-therapeutic strategy. In phase III, diagnostic test-therapeutic randomized clinical trials aim to assess the benefits and harms of the new diagnostic-therapeutic strategy versus the present strategy. Phase IV comprises large surveillance cohort studies that aim to assess the effectiveness of the new diagnostic-therapeutic strategy in clinical practice. Conclusion: As common in clinical research, giving excessive weight to the results of single studies and trials is likely to divert from the totality of evidence obtained through the systematic reviews of these studies, conducted with rigorous methodology and statistical methods. (Hepatology 2014;60:408-418)

AB - The diagnostic research process can be divided into five phases, designed to establish the clinical utility of a new diagnostic test-the index test. The aim of the present review is to illustrate the study designs that are appropriate for each diagnostic phase, using clinical examples regarding liver fibrosis diagnosed with transient elastography, when possible. Phase 0 is the preclinical pilot phase during which the validity, reliability, and reproducibility of the index test are assessed in healthy and diseased people. Phase I is designed to describe the distribution of the index test results in healthy people and its normal values. Phase IIA comprises studies designed to estimate the accuracy (sensitivity and specificity) of the index test in discriminating between diseased and nondiseased people in a clinically relevant population. Phase IIB studies allow the comparison of the accuracy of different index tests; Phase IIC studies aim to evaluate the possible harms of incorporating the index test in a diagnostic-therapeutic strategy. In phase III, diagnostic test-therapeutic randomized clinical trials aim to assess the benefits and harms of the new diagnostic-therapeutic strategy versus the present strategy. Phase IV comprises large surveillance cohort studies that aim to assess the effectiveness of the new diagnostic-therapeutic strategy in clinical practice. Conclusion: As common in clinical research, giving excessive weight to the results of single studies and trials is likely to divert from the totality of evidence obtained through the systematic reviews of these studies, conducted with rigorous methodology and statistical methods. (Hepatology 2014;60:408-418)

UR - http://www.scopus.com/inward/record.url?scp=84903211610&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903211610&partnerID=8YFLogxK

U2 - 10.1002/hep.26948

DO - 10.1002/hep.26948

M3 - Article

VL - 60

SP - 408

EP - 418

JO - Hepatology

JF - Hepatology

SN - 0270-9139

IS - 1

ER -